A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
American Hospital and Koç University Hospital have joined the Mayo Clinic Care Network. https://lnkd.in/gSADwMD4
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Great to see William Morice II, MD, PhD featured in Becker's Healthcare on what’s next for #DigitalHealth https://lnkd.in/gXTzqAKF
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Learn about Mayo Clinic Laboratories' #lupus testing, offered in collaboration with Progentec Diagnostics, Inc., for patients affected by systemic lupus erythematosus.
In this episode of “Answers From the Lab,” Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guest Donald Thomas, M.D., a rheumatologist and lupus researcher. They discuss how Mayo Clinic Laboratories’ suite of innovative lupus testing, offered in collaboration with Progentec Diagnostics, Inc., is enhancing the care and quality of life for patients affected by systemic lupus erythematosus. https://bit.ly/4e9aXt0
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Learn about Mayo Clinic Laboratories' #lupus testing, offered in collaboration with Progentec Diagnostics, Inc. for patients affected by systemic lupus erythematosus.
In this episode of “Answers From the Lab,” Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guests Bernard Rubin, D.O., MPH, chief medical officer of Progentec Diagnostics, Inc., and Melissa Munroe, M.D., Ph.D., chief scientific officer and principal investigator of Progentec Diagnostics. They discuss Mayo Clinic Laboratories’ suite of innovative lupus testing, offered in collaboration with Progentec Diagnostics, for patients affected by systemic lupus erythematosus. https://bit.ly/3Tu8Tnc
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Comprehensive #diagnostics ensure that women receive the most accurate screening, which can lead to early intervention and better outcomes. https://lnkd.in/gvnVNzv5
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
What are the latest advancements in #Alzheimers disease testing and treatment? Listen to Bobbi Pritt and William Morice II, MD, PhD from Mayo Clinic Laboratories to learn more.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the latest advancements in Alzheimer’s disease testing and treatment. https://bit.ly/4dSdaJ7
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
There is a delicate balance between risk-taking and maintaining the integrity of core values in #healthcare. I had the opportunity to share my views in Becker's Healthcare on how we balance these risks while facilitating #innovation. https://lnkd.in/gEqGshaU
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Accurate #diagnosis for #dementia and #Alzheimers is critical for treatment. Learn how Mayo Clinic Laboratories is making an impact in this space. https://lnkd.in/gPJ7dj8j
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Learn about the development of Mayo Clinic Laboratories' innovative bile acid malabsorption panel and its transformative potential for patient care.
Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. This new bile acid malabsorption panel simplifies diagnosis by eliminating the need for special diets or prolonged stool collection. Discover how this innovative test is transforming clinical practice and enhancing patient outcomes. https://bit.ly/3SOzGdl
A proven healthcare strategist with demonstrated fiscal and operational excellence in both traditional and nontraditional sectors.
Michael Shannon recently joined the Mayo Clinic Board of Trustees, bringing an extensive background in hospitality and finance. https://lnkd.in/duMKeRu8
